Business
Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine - Fortune

What the report says
Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.
Loading debate for this article…
Other publishers covering this story
No additional verified coverage is currently clustered with this report.

How Permanent Secretary Ben Kumumanya’s Directives Are Reshaping Uganda’s Anti-Corruption Battle in Local GovernmentWatchdog Uganda